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The effector AWR5 from the plant 
pathogen Ralstonia solanacearum 
is an inhibitor of the TOR signalling 
pathway
Crina Popa1,2, Liang Li1, Sergio Gil2, Laura Tatjer3, Keisuke Hashii4, Mitsuaki Tabuchi4, 
Núria S. Coll1, Joaquín Ariño3 & Marc Valls1,2
Bacterial pathogens possess complex type III effector (T3E) repertoires that are translocated inside the 
host cells to cause disease. However, only a minor proportion of these effectors have been assigned 
a function. Here, we show that the T3E AWR5 from the phytopathogen Ralstonia solanacearum is an 
inhibitor of TOR, a central regulator in eukaryotes that controls the switch between cell growth and 
stress responses in response to nutrient availability. Heterologous expression of AWR5 in yeast caused 
growth inhibition and autophagy induction coupled to massive transcriptomic changes, unmistakably 
reminiscent of TOR inhibition by rapamycin or nitrogen starvation. Detailed genetic analysis of these 
phenotypes in yeast, including suppression of AWR5-induced toxicity by mutation of CDC55 and TPD3, 
encoding regulatory subunits of the PP2A phosphatase, indicated that AWR5 might exert its function 
by directly or indirectly inhibiting the TOR pathway upstream PP2A. We present evidence in planta that 
this T3E caused a decrease in TOR-regulated plant nitrate reductase activity and also that normal levels 
of TOR and the Cdc55 homologues in plants are required for R. solanacearum virulence. Our results 
suggest that the TOR pathway is a bona fide T3E target and further prove that yeast is a useful platform 
for T3E function characterisation.
Many bacterial pathogens use a type III secretion system (T3SS) to inject a suite of proteins inside the host cell1. 
These proteins are referred to as type III effectors (T3Es), and play a central role in bacterial survival and disease 
development2. T3Es manipulate host cell pathways by mimicking key host proteins or mediating changes in their 
subcellular localization, by targeting plant-specific transcription factors, by inhibiting translation and metabolic 
stress pathways or exploiting a specific form of host-mediated fatty acid modification3–5. The functional study of 
T3Es from phytopathogenic bacteria has raised a tremendous interest in the last years6,7. The number of T3Es 
identified is growing at a very fast pace as more bacterial genomes become available, revealing complex reper-
toires that feature internal redundancy, which complicates their study6. However, only in a few cases the function 
of this kind of effectors in planta has been identified.
Heterologous production in Saccharomyces cerevisiae has offered promising and effective strategies to 
characterize bacterial T3Es8. Seminal work with YopE showed that this T3E caused specific growth inhibi-
tion and cytoskeletal alteration, an activity conserved in yeast and mammalian cells9. Functional analyses of 
plant-associated T3E in yeast have revealed other effector-triggered phenotypes including cell death, suppression 
of apoptosis or perturbation of host cellular processes, such as MAPK signalling or sphingolipid synthesis10–12. 
All these findings strengthen the premise that many bacterial T3E target universal eukaryotic processes so that 
S. cerevisiae can be exploited to elucidate their molecular function and to investigate target-effector interactions8,13.
The TOR complex 1 (TORC1) is a central regulator of cell growth in response to nutrient availability and stress 
conditions by controlling diverse cellular processes, including transcriptional activation, ribosome biogenesis 
or autophagy14 (Fig. 1a). This complex contains the Tor1 or Tor2 protein kinases and can be inhibited by the 
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drug rapamycin. In yeast, TORC1 acts by controlling three major cell components: the kinase Sch9, Tap42 and 
its associated phosphatases and the ATG1 complex14,15. Thus, TORC1 modulates nitrogen catabolite repression 
and diverse stress responses by controlling the activity of several phosphatases, such as protein phosphatase 2A 
(PP2A) or Sit 4, often by modifying their interaction with regulatory subunits (Fig. 1a15).
Ralstonia solanacearum is emerging as a model system to study plant-pathogen molecular interactions and 
T3E function16. This soil-borne bacterium is the causing agent of bacterial wilt, a disease caused when the bac-
terium growing in plant extracellular spaces (apoplast) infects the xylem vessels, where it multiplies extensively 
and blocks water flow17. R. solanacearum has been ranked as the second most important bacterial plant path-
ogen18, due to its high persistence and wide geographical distribution and host range, as it infects more than 
200 plant species, including important agricultural crops such as tomato and potato19. Of more than 70 T3Es 
identified in the reference strain GMI1000, only for two of them a defined role in planta has been assigned16. 
AWRs (named after a conserved alanine-tryptophan-arginine tryad and also called RipAs) are one of the multi-
genic families of T3Es conserved in all R. solanacearum strains17, with orthologues in other bacterial pathogens 
such as Xanthomonas strains, Acidovorax avenae or Burkholderia spp.20. A low protein similarity has also been 
described between AWRs and the Xanthomonas oryzae pv. oryzae effector XopZ, which was shown to be involved 
in virulence and suppression of host basal defence21. Translocation assays have proven AWRs as bona fide R. 
solanacearum type III secreted effectors20,22,23. However, sequence information on AWR proteins gives no clue 
on their putative function. In a previous study, we showed that the AWR T3E family collectively contributes to R. 
solanacearum virulence, as a mutant bacterium devoid of all AWR multiplies 50-fold less than the wild-type strain 
on eggplant and tomato plants. Functional analysis of AWRs also demonstrated that their expression in different 
plant species triggers varying defence responses20. Functional analyses for each AWR showed that AWR5 had 
an important contribution in virulence and also caused the most dramatic plant responses. In addition, we have 
recently found that awr5 is one of the most highly expressed genes when R. solanacearum grows inside the plant 
host (Marina Puigvert, unpublished results). Association genetics combining genomic data from R. solanacearum 
strains and their pathogenicity on eggplant, pepper and tomato accessions identified AWR5 amongst the three 
T3Es highly associated to virulence24.
In this work we take advantage of the yeast system to characterize AWR5 function. Heterologous expression 
of AWR5 in S. cerevisiae resulted in dramatic growth inhibition of yeast cells. We show that this effect on yeast 
growth is caused by inhibition of the central regulatory TOR pathway. Importantly, AWR5 impact on the TOR 
pathway is conserved in both yeast and plants, revealing a previously unknown T3E mode of action maintained 
in evolutionary distant organisms. Moreover, our work further validates yeast as an excellent platform to uncover 
T3E function.
Results
Expression of the R. solanacearum awr type III effector family in yeast causes growth inhibition. 
To investigate the function of the AWR bacterial effectors in eukaryotic cells, we expressed the five awr genes from 
R. solanacearum GMI1000 in S. cerevisiae. In a first step, awrs were cloned in the high-copy-number vector pAG-
426GAL, where they are transcribed from the strong galactose-inducible GAL1 promoter. The resulting plasmids 
were introduced in yeast and the transformed strains grown overnight, then serially diluted and plated either in 
repressing media (glucose) or inducing media (galactose). It was observed that, except for AWR4, these effectors 
inhibited growth to different extents, as observed by the inability to form macroscopic colonies on inducing 
media (Supplementary Fig. S1). AWR1, 2, 3 and 5 caused a strong toxicity upon induction, but AWR5 showed the 
most dramatic effect, inhibiting yeast growth even in non-inducing conditions. The phenotype seemed specific 
for AWR effectors, as it was not observed when a control gene (GFP) was expressed (Supplementary Fig. S1). The 
full-length AWR5 protein was required for functionality, as expression of split variants of AWR5 (N-terminal or 
C-terminal halves, or the central region) did not cause toxicity (Supplementary Fig. S1).
To evaluate the phenotype in more physiological conditions and ensure construct stability and tight control 
of effector transcription, we integrated the bacterial genes in the yeast genome under the control of a repressible 
Tet-Off promoter. When the resulting strains bearing awrs or a control GUS gene were plated in the absence of 
the repressor doxycycline, only expression of awr5 reproduced the dramatic growth arrest (Fig. 1b). The absence 
of toxicity for AWR1, 2 and 4 could not be attributed to a lack of expression, as the full-length proteins were read-
ily detected in yeast cells (Supplementary Fig. S2). Thus, we concentrated on the characterization of the growth 
inhibition caused by awr5 expression.
Characterization of the AWR5-dependent growth inhibition phenotype. Yeast growth inhibition 
was also apparent upon AWR5 production in liquid cultures as indicated by a rapid stagnation of cell density over 
time (not shown) and a clear decrease in the number of growing cells (Fig. 1c). Growth inhibition kinetics paral-
leled with an increase in awr5 RNA (Supplementary Fig. S3) and protein levels (Fig. 1d). Microscopic observation 
of strains producing AWR5 revealed the presence of budding cells at similar proportions to cells not producing 
the bacterial effector (Supplementary Fig. S4a). Thus, it could be ruled out that this protein specifically alters the 
cell cycle.
Expression of awr5 caused strong growth inhibition but not cell death, as deduced from methylene blue stain-
ing of cells bearing awr5 in the absence of doxycycline (Supplementary Fig. S4a) and from counting of viable 
cells able to form colonies after 6 h of awr5 expression (Supplementary Fig. S4b). Similarly, growth arrest in cells 
expressing awr5 was not likely caused by defects in cell wall construction leading to cell lysis, since it was not 
eliminated by osmotic stabilization with 10% sorbitol (Supplementary Fig. S5). In contrast, determination of cell 
size upon expression of awr5 showed significant changes, visible after 8 h of induction, with AWR5-producing 
cells showing an average diameter of 4.96 ± 0.03 μ m, while that of non-expressing cells was over 5.3 ± 0.06 μ m 
(Supplementary Fig. S4c).
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Figure 1. Expression of awr5 effector inhibits yeast growth. (a) Schematic view of the Saccharomyces 
cerevisiae TORC1-regulated pathways. The TORC1 complex is a central growth regulator, controlling the 
balance between growth and quiescence. Continuous and dotted lines represent, respectively, signaling events 
regulated by active and inactive TORC1. (b) Growth on solid medium of yeast strains expressing awr effectors. 
Yeast strains bearing awr genes fused to GFP tag or a GFP control were subjected to serial 10-fold dilutions and 
spotted onto solid SD-Ura+ doxycycline (repressing medium) and SD-Ura (inducing medium). Photographs 
were taken after 2 days of growth. (c) Growth kinetics in liquid medium of yeast cells harboring awr5 or a GFP 
control. Yeast cells harboring awr5 or a GFP control were grown in SD-Ura+ dox (− AWR5) and SD-Ura  
(+ AWR5) liquid media and dispersed on SD-Ura+ dox plates. The logarithm of colony forming units (CFU) per 
ml is shown over time. Error bars indicate standard errors for 2 biological replicates. (d) Immunoblot analysis of 
AWR5 protein levels. Total protein was extracted from cultures shown in Fig. 1c and immunoblotted using an 
anti-GFP antibody. The black arrowhead indicates AWR5-GFP protein. All experiments were performed at least 
three times, with similar results.
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Previous reports studying effectors from Pseudomonas syringae or Xanthomonas euvesicatoria had shown that 
some of them caused growth arrest when yeast was forced to respire10,11. To verify if respiration affected AWR5 
toxicity in yeast, we grew serial dilutions of the strain producing this protein or a control gene (β -glucuronidase, 
GUS) onto solid medium containing the non-fermentable carbon sources ethanol and glycerol. As observed in 
Supplementary Fig. S5, the toxic effect due to AWR5 was maintained under these conditions.
In summary, we established that production of the full-length AWR5 protein in yeast targeted a cellular pro-
cess leading to growth inhibition and decreased cell size, but not involving an evident cell cycle arrest or cell 
death.
Expression of awr5 mimics the transcriptional changes induced by the TORC1 inhibitor rapamycin. 
To understand the molecular basis of awr5 toxicity in yeast and to highlight putative functional targets, we con-
sidered the identification of possible changes at the mRNA level caused by expression of the effector. To this end, 
we carried out a genome-wide transcriptomic analysis using DNA microarrays in yeast cells with awr5 expression 
induced for 2, 4 and 6 h. This time-course was selected according to the previously characterized growth effect 
(Fig. 1c). DNA microarray analysis yielded 3763 genes with valid data for all 3 time-points. We observed that 
induction of awr5 expression produced relevant time-dependent changes in the transcriptomic profile that, in 
most cases, could be observed after 4 and 6 h of induction. The mRNA level of 766 genes was modified at least 
2-fold, with 319 genes induced and 447 repressed. The functional assignment of induced genes revealed a strik-
ing excess of genes subjected to nitrogen catabolite repression (NCR)25, such as MEP2, GAP1, DAL5, CPS1 or 
DUR1,2, whereas among the repressed genes there was a vast excess of genes encoding ribosomal proteins or 
involved in ribosome biogenesis. This profile was reminiscent of that reported by several laboratories for inhibi-
tion of the TORC1 pathway15.
We took advantage of recent work in our laboratory in which the transcriptomic profile in response to 1 h 
of exposure to rapamycin had been generated26. Combination of this data with that obtained here after awr5 
expression yielded 2774 genes with expression information in both conditions. Figure 2a shows the correspond-
ence between changes produced in response to awr5 with those caused by rapamycin. It can be observed that 
whereas the correlation is relatively poor shortly after awr5 induction (correlation coefficient = 0.402), the simi-
larity between both responses becomes evident after 4 h and, particularly, after 6 h of awr5 induction (correlation 
coefficients 0.569 and 0.739, respectively). We then selected among the 766 genes whose expression changed at 
least 2-fold those with data for the rapamycin treatment (596 genes) and subjected this set of genes to clustering 
analysis. Figure 2b clearly documents that the time-dependent transcriptional response to expression of awr5 
matches that provoked by rapamycin treatment (correlation coefficient of 0.872 when compared with awr5 data 
after 6 h of expression). It can be observed that clusters 1 and 2 -and to some extent also cluster 3- are enriched in 
induced genes related to metabolism of nitrogen (mostly amino acids), whereas regarding the repressed genes, 
cluster 5 includes genes involved in translation and cluster 6 is enriched in genes encoding ribosomal proteins or 
members of the RiBi (ribosome biogenesis) regulon. All these results indicate that expression of bacterial awr5 in 
yeast triggers a response that mimics the inhibition of the TORC1 pathway.
These transcriptomic data were validated by performing quantitative RT-PCR analysis on a subset of genes 
from different TORC1-regulated pathways, which showed altered expression levels in response to awr5 (Fig. 3b). 
As expected, awr5 expression resulted in a decrease of the levels of the TOR-activated STM1 and NSR1 genes, 
which are involved in yeast growth27,28. In contrast, the levels of the TOR-repressed GAP1 and MEP2, which 
control nitrogen catabolite repression29, increased in response to awr5 expression. Similar results were obtained 
when promoter activity was measured using fusions to the β -galactosidase reporter: awr5 expression resulted in 
increased GAP1 and MEP2 promoter output (Fig. 3b).
Mutations in two genes involved in the TORC1 pathway rescue the yeast growth inhibition 
caused by AWR5. Since AWR5 mimicked rapamycin treatment in yeast, we tested whether disruption of 
FPR1-encoding the rapamycin-binding protein Fpr1 that inhibits the TORC1 kinase in the presence of rapa-
mycin15 rescued the AWR5-triggered phenotype. Growth inhibition caused by AWR5 was maintained in the 
fpr1 strain (Fig. 4a), indicating that the bacterial effector acts on TORC1 through a different mechanism than 
rapamycin.
In order to ascertain which point of the TOR-controlled pathways was targeted by AWR5 we analysed yeast 
strains with altered levels of different genes mediating TORC1 signalling. Interestingly, the strains mutated in the 
PP2A regulatory or scaffold subunits cdc55 or tpd3 did not show AWR5-triggered growth inhibition (Fig. 4b). 
This indicated that these PP2A subunits are essential for AWR5 to cause its phenotype. These results were also 
corroborated by testing promoter activity of GAP1 fused to the β -galactosidase reporter in wild type and cdc55 
mutant strains. Our results clearly showed that CDC55 was required for the increase in GAP1 promoter activity 
that occurs in response to awr5 expression (Fig. 4c).
On the contrary, AWR5 did not seem to target the PP2A catalytic subunit, since AWR5-mediated growth 
inhibition could not be rescued by overexpression or conditional mutation of the two redundant genes (pph21, 
22) encoding this subunit (Supplementary Fig. S6a,b). Any other mutant (rts1, tip41, ppm1 and gln3) or overex-
pressor (SIT4) in genes related to signalling through the TORC1 pathway that we tested did not show reversion of 
AWR5-mediated growth inhibition. However, we could not detect interaction between Cdc55 or Tpd3 and AWR5 
in yeast using co-immunoprecipitation (Supplementary Fig. S7a,b). Although the transcription profile was spe-
cifically compatible with TORC1 inhibition, we checked whether AWR5 had any impact on TORC2. As shown in 
supplementary Fig. S8, AWR5 does not interfere with TORC2, because a dominant active ypk2 mutant (one of the 
major downstream components of the TORC2 pathway) did not rescue growth inhibition caused by AWR5 (Fig. 
S8a) and expression of the effector did not alter the actin cytoskeleton, a target of the TORC2 pathway (Fig. S8b). 
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In addition, AWR5 also did not co-immunoprecipitate with the Lst8, a shared component of TORC1 and 
TORC230 (Supplementary Fig. S7c).
To determine whether Cdc55 was required for downstream AWR5-mediated responses, we carried out a new 
transcriptomic analysis, in this case by direct sequencing of RNAs (RNA-seq) in wild type and cdc55 cells express-
ing awr5 for 6 h. Analysis of the wild type strain showed a response congruent with that observed previously using 
DNA microarrays, with a correlation coefficient of 0.63 in the genes detected as induced by both methodologies 
(Supplementary Fig. S9). In addition, among the top 25 most induced genes detected by microarray analysis, 13 
were also ranked as such by RNA-seq. Comparison of the profiles of the wild type and the cdc55 strains after 6 h 
of awr5 induction showed that mutation in CDC55 dramatically attenuated the transcriptomic effects caused by 
awr5 expression. As illustrated in Fig. 5a, 512 genes were induced in the wild type strain upon awr5 expression 
and only 212 in the cdc55 strain (of which only 144 were also induced in wild type cells). This effect was particu-
larly evident in repressed genes, since the cdc55 mutation affected almost 90% of the genes repressed by awr5 
expression in the wild type strain. The attenuation of the transcriptional response to AWR5 could clearly be 
observed by plotting the 100 genes showing highest induction (Fig. 5b, upper panel) or repression (Fig. 5b, lower 
panel) in wild-type cells and comparing to their expression in cdc55 cells.
It was apparent that many of the highly induced genes in response to AWR5 expression, which belong to the 
NCR and the mitochondrial retrograde pathways, decreased their expression in the absence of the regulatory 
subunit of PP2A. Indeed, 26 out of 28 NCR and RTG genes31 ranking as top 100 induced decreased their expres-
sion more than 50% in cdc55 cells. Similarly, a significant number of genes whose expression was decreased in 
response to AWR5 were clearly no longer repressed in cdc55 cells. However, the effect was not homogeneous. 
For instance the transcripts showing little or no change in awr5-induced repression upon deletion of CDC55 are 
Figure 2. Expression of bacterial awr5 in yeast mimics the transcriptomic changes caused by inhibition 
of the TORC1 pathway. (a) Changes in mRNA levels caused by expression of awr5 (X-axis, log2 space) for the 
set of 2774 genes with valid data for all three time-points were plotted against the corresponding values after 
1 h treatment with 200 ng/ml rapamycin (Y axis, log2 space). “CC” figures indicate the calculated correlation 
coefficient among both sets of data for each time-point. (b) The set of 596 genes presenting at least 2-fold 
changes in mRNA levels upon expression of awr5 and with valid data for the rapamycin treatment were 
clustered (Euclidean distance, average linkage) using Cluster 3.0 software57 and are represented with the Java 
Treeview software, version 1.1.6r458. Numbers in red denote selected clusters referred to in the main text and 
number between parentheses designate the p-value for the indicated GO annotations.
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largely enriched in genes involved in ribosome biogenesis and rRNA processing (Supplementary Fig. S10). This 
could be expected, as TOR-regulated expression of these genes is mostly PP2A-independent.
Taken together, these results indicate that the inability to form PP2A complexes containing Cdc55 not only 
neutralizes the severe growth defect caused by expression of awr5, but also substantially minimizes the transcrip-
tional alterations derived from such expression. These data further supported the notion that the PP2A complex 
might mediate the phenotype caused by the AWR5 effector.
awr5 expression constitutively activates autophagy. It is known that TORC1 regulates autophagy 
in yeast via inhibition of the ATG1 complex (Fig. 1a and32). Our microarray data showed that expression of 
awr5 increased the expression of diverse autophagy genes, such as ATG8 or ATG14, which indicates activation 
of this process. In order to confirm whether autophagy was affected by awr5 expression, autophagic flux was 
monitored in yeast cells constitutively expressing GFP-ATG8 (Fig. 6). Proteolysis of GFP-ATG8 in the vacuole 
during autophagy results in the accumulation of the GFP moiety. Hence, detection of free GFP levels by western 
blot analysis can be used as readout of the autophagic rate33. Expression of awr5 led to a dramatic accumulation 
of GFP in yeast cells, indicating an increased autophagic flux (Fig. 6a). As a control, we subjected yeast cells to 
nitrogen starvation, which resulted, as expected, in an increase of free GFP levels (Fig. 6b). Interestingly, free 
GFP levels in awr5-expressing cells relative to GFP-ATG8 were higher than in nitrogen-starved cells, indicating 
that AWR5 expression induces autophagy more potently than nitrogen starvation does. Next, we tested whether 
Cdc55 was involved in AWR5-triggered autophagy in yeast. Although GFP-ATG8 levels were slightly higher in 
cdc55 mutant cells expressing awr5, autophagy was similarly induced in both strains (Fig. 6a). awr5 expression 
was analysed and similar levels were detected in wild type and cdc55 mutant cells (Fig. 6c). These findings indi-
cated that AWR5-mediated autophagy induction occurs independently of Cdc55 in yeast.
AWR5 alters the TOR pathway in plants. Since heterologous expression of a T3E from R. solanacearum 
in yeast altered the TORC1 pathway, it was plausible that the effector had a similar effect in its natural context, 
i.e. when translocated inside the cells of plants infected by the pathogen. In plants, it has been shown that TOR 
silencing results in activation of nitrogen recycling activities and reduces primary nitrogen assimilation, meas-
ured by nitrate reductase activity34. In order to test whether awr5 expression resulted in TOR inhibition in plants 
we thus used this activity as readout. Transient expression of awr5 in Nicotiana benthamiana leaves resulted in a 
significant reduction of nitrate reductase activity compared to the control (GUS) (Fig. 7a). Leaky expression of 
awr5 prior to induction may account for the slightly lower nitrate reductase activity values in leaves transformed 
with awr5. awr5 expression did not significantly affect the activity of the TOR-independent, constitutive enzyme 
Figure 3. Transcriptional response of TORC1-related genes to awr5 expression. (a) qRT-PCR experiments 
showing relative gene expression of TORC1 downstream targets. Gene expression of nitrogen catabolite 
repression (NCR)-sensitive GAP1 and MEP2 and ribosomal biogenesis STM1 and NSR1 genes was tested in 
yeast strains expressing awr5 (+ AWR5 (− dox)) 6 hours after induction. Error bars represent standard errors 
from 2 biological replicates. (b) β -galactosidase activities from yeast cells bearing awr5. Promoter activities of 
GAP1 and MEP2 were determined 6 hours after growth in SD-Ura+ dox (− AWR5) and SD-Ura (+ AWR5). 
Data represent the means and standard errors of 4 independent clones. All assays were repeated at least twice 
with similar results.
www.nature.com/scientificreports/
7Scientific RepoRts | 6:27058 | DOI: 10.1038/srep27058
Figure 4. cdc55 and tpd3 mutations affecting PP2A protein phosphatase activity suppress AWR5-induced 
yeast growth inhibition. (a) Growth on solid medium of control (WT) and an fpr1 mutant carrying awr5 
under the control of a Tet-Off promoter. Serial 10-fold dilutions were spotted onto solid SD-Ura+ doxycycline 
(− AWR5) and SD-Ura (+ AWR5). (b) Growth on solid medium of control (WT) and TORC1-related 
yeast mutants containing plasmid carrying awr5. Serial 10-fold dilutions were spotted onto solid SD-Ura+ 
doxycycline (− AWR5) and SD-Ura (+ AWR5). Photographs were taken after 3 days of growth. (c) GAP1 
promoter activity from plasmid pGAP1-LacZ in wild-type (WT) and mutant cdc55 yeast cells bearing awr5 or a 
control gene (GFP). β -galactosidase activity was measured 6 hours after growth in SD-Ura+ dox (− AWR5) and 
SD-Ura (+ AWR5). Values represent the means and standard errors of 4 independent clones. All experiments 
were performed three times with similar results.
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glucose-6-phosphate dehydrogenase (Fig. 7b). This clearly indicates that the decrease in the TOR- dependent 
nitrate reductase activity is specifically caused by awr5 expression in plants.
The mechanisms by which AWR5 alters the TOR pathway in plants remains to be determined. Transient 
expression of awr5 did not result in autophagy induction in N. benthamiana leaves expressing the autophagy 
marker GFP:ATG8a (Supplementary Fig. S11a). In addition, we could not detect direct interaction between 
AWR5 and TOR1 by co-immunoprecipitation using N. benthamiana leaves transiently over-expressing tagged 
versions of the two proteins (Supplementary Fig. S11b).
To further prove that AWR5 impacts the plant TOR pathway we infected Arabidopsis thaliana wild-type Col-0 
plants, TOR1-silenced plants (TOR RNAi)35 and two mutant lines disrupted in the genes encoding either of the 
CDC55 homologues (b55α and b55β)36 with R. solanacearum and recorded the appearance of wilting symp-
toms over time. TOR1-silenced lines were slightly more resistant to bacterial infection (Fig. 7c) and the two 
lines mutated in the CDC55 homologues showed a striking resistance to infection as compared to the wild-type 
Arabidopsis (Fig. 7d), indicating that AWR5 effector may be targeting the TOR pathway in both plants and yeast. 
Although TOR RNAi lines have been previously reported to be slightly reduced in growth compared35, in our 
growing conditions both TOR RNAi and b55 mutants were indistinguishable from wild-type plants (Fig. S12), 
ruling out the possibility that their altered response to R. solanacearum infection was due to reduced surface of 
interaction.
Discussion
In this work, we have produced R. solanacearum AWR effectors in yeast and have found that AWR5 impacts the 
TORC1 pathway, an essential component of eukaryotic cells. The premise for using Saccharomyces cerevisiae 
was that this organism carries out most eukaryotic processes and, unlike the host cells where T3E are natu-
rally injected, it shows less gene redundancy and lacks resistance components that counteract and mask effector 
Figure 5. Mutation of CDC55 greatly attenuates AWR5 impact on the yeast transcriptional profile. (a) 
Venn diagram showing the number of genes whose expression was considered to be induced (top) or repressed 
(bottom) by expression of AWR5 in wild-type and cdc55 cells for a set of 5732 genes with valid data for both 
strains. (b) Plots of the log2 values for the changes in the level of expression induced by expression of AWR5 in 
both wild-type (open circles) and cdc55 strains for the 100 most upregulated (top) and 100 most downregulated 
(bottom) genes in the wild-type strain (open circles). Symbols for the expression values for the cdc55 strain are 
depicted as follows. For the induced genes: open triangles, the NCR family, as defined previously25; the RTG 
group (open squares) comprises the genes described as documented targets for the Rtg1 or Rtg3 transcription 
factors as defined in59. Genes not included in these categories are designated as “others” (closed circles). The 
genes downregulated in the wild-type strain are classified into one of three possible families: Ribi regulon (open 
squares), ribosomal proteins (open triangles), protein translation (open diamonds), and others (closed circles), 
as defined in59.
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Figure 6. awr5 expression induces constitutive autophagy, independently of Cdc55-PP2A activity. (a) 
Immunodetection of GFP-ATG8 processing in wild-type and mutant cdc55 yeast strains expressing awr5. 
Wild-type (WT) and mutant cdc55 yeast cells bearing awr5 gene were grown in SD-Ura+ dox (− AWR5) and 
SD-Ura (+ AWR5). Total protein extracts were immunoblotted using anti-GFP antibody. The black and the 
empty arrowhead indicate, respectively, GFP-ATG8 fusion protein and cleaved GFP. The asterisk denotes a 
degradation product of AWR5-GFP protein. (b) Wild-type cells carrying GFP-ATG8 grown in nitrogen-rich 
(N+ ) or nitrogen-depleted (N− ) medium were used as a control of GFP-ATG8 processing and induction of 
autophagy in N− conditions. (c) AWR5 protein levels in wild-type and mutant cdc55 yeast cells. Total protein 
was extracted and immunoblotted using anti-GFP antibody. The black arrow indicates AWR5-GFP protein. All 
experiments were performed at least three times, with similar results.
Figure 7. Interplay between AWR5 and TOR in planta. Effect of awr5 transient expression on (a) nitrate 
reductase (NR) activity or (b) glucose-6-phosphate dehydrogenase (G6PdH) in Nicotiana benthamiana. Full 
leaves of N. benthamiana were agroinfiltrated with constructs bearing awr5 or a control gene (GUS). Total 
protein extracts were used to determine NR and G6PdH activity at 0 and 1 hours post-estradiol induction (hpi). 
Error bars indicate standard errors of 2 biological replicates for NR and 3 for G6PdH. TOR (c) and its signalling 
component B55 (d) are involved in plant defence responses against R. solanacearum invasion. Five-week 
old plants grown in Jiffy pots were inoculated with R. solanacearum GMI1000 at an OD600 = 0.1 and wilting 
symptoms were recorded over time according to a disease index scale (0: no wilting, 1: 25% wilted leaves, 2: 
50%, 3: 75%, 4: death). The experiment was repeated twice using at least 20 plants in each. Error bars indicate 
standard errors.
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function37. For instance, gain-of-function analyses of T3E in plants are often hampered by a hypersensitive 
response (HR), a programmed cell death associated with recognition of effectors or effector virulence activities38.
A number of studies have successfully used S. cerevisiae as a model to identify T3E targets8,13. Toxicity -ranging 
from growth arrest to cell death- is the most common phenotype observed in these studies. However, this is not 
a widespread phenomenon when R. solanacearum T3E are expressed in yeast, as only 6 out of 36 effectors rep-
resenting the repertoire of strain GMI1000 caused substantial growth inhibition (this work and39). Interestingly, 
four out of the six toxic T3E encode AWR proteins, suggesting a distinct function for this effector family in 
bacterial-host interactions. Cell growth inhibition caused by T3E has been traced back to interference on vesicle 
trafficking, disruption of the cytoskeleton or MAP Kinase alteration8, providing important clues on T3E function. 
In the case of AWR5, we show that it targets a novel cellular process, namely, the TORC1 pathway.
As mentioned above, the TORC1 protein complex regulates the transition between growth and quiescence in 
response to nutrient status and can be inhibited by rapamycin. TORC1 acts by controlling three major cell com-
ponents: the kinase Sch9, Tap42, its associated phosphatases and the ATG1 complex14,15. Active TORC1 directly 
phosphorylates Sch9 -the orthologue of the mammalian S6 kinase-, which induces RiBi genes, such as STM1 
and NSR1, to increase translation and promote growth (Fig. 1a). In addition, when TORC1 is active, the essen-
tial downstream regulatory protein, Tap42, is phosphorylated and associates with the catalytic subunits of the 
PP2A and PP2A-like phosphatases, which are retained in membranes interacting with TORC114. Finally, active 
TORC1 can inhibit autophagy by phosphorylation of ATG13, which prevents association with the ATG1 kinase 
and subsequent autophagy induction32. On the contrary, when TORC1 is inactivated by rapamycin treatment or 
nitrogen starvation, Tap42 and the PP2A and PP2A-like phosphatases are released to the cytosol and activated, 
allowing expression of stress genes and NCR genes such as GAP1 and MEP215 (Fig. 1a). This gene reprogramming 
takes place through PP2A-mediated inhibition of nuclear export of the Msn2/4 factors and PP2A/Sit4-mediated 
dephosphorylation and subsequent translocation of Gln3 to the nucleus. Our gene expression analyses and bio-
chemical characterizations showed that the bacterial effector AWR5 interferes with the TORC1-regulated path-
ways, repressing ribosome biogenesis and translation and activating autophagy and stress responses. Activation 
of the latter, which are incompatible with growth, could explain the dramatic growth defects triggered by AWR5 
in yeast. Our findings that mutants in two PP2A subunits (cdc55 and tpd3) totally rescued this phenotype strongly 
support that AWR5 impacts TORC1-regulated pathways in eukaryotic cells.
As mentioned before, most TORC1-controlled effects occur through two major effector branches, mediated 
by the Sch9 kinase and by complexes of Tap42 and the phosphatases (mainly PP2A and Sit4). The wide transcrip-
tomic impact of AWR5 on all TORC1-controlled pathways, mimicking the effect of rapamycin or nitrogen star-
vation, could be explained by assuming that AWR5 targets multiple hits downstream the pathway. Along this line, 
downstream components of the TOR pathway have already been involved in plant defense: PP2A was found to 
negatively regulate pathogen perception40 and PP1A is targeted by a Phytophtora infestans effector41,42. However, 
the most likely scenario is that AWR5 would target a few or even a single target controlling all these processes. 
If this were the case, AWR5 would exert its function inhibiting TORC1 upstream of PP2A, thus causing Sch9 
inhibition, autophagy activation and the release of Tap42 and PP2A phosphatase subunits. The notion of a single 
target is reinforced by the fact that only a limited number of T3E molecules are injected into the host cell to exert 
their function. Along this line, leaky expression of awr5 from a tet-off promoter in the presence of the repressor 
doxycycline had a detectable effect on yeast growth.
The observation that deletion of genes encoding two components of the PP2A heterotrimeric forms, CDC55 
and TPD3, abolishes the dramatic growth defect of cells expressing awr5 suggests that in spite of the wide tran-
scriptional effect caused by awr5 expression, the major reason for AWR5 toxicity lies downstream PP2A and 
indicates that the formation of this heterotrimer is essential for the negative effect of AWR5 to take place. In this 
regard, it is worth noting that deletion of TPD3 and of CDC55 yields yeast cells resistant to rapamycin, whereas 
that of RTS1 does not. Moreover, it has been proposed that an active TORC1 pathway promotes the associa-
tion of Tap42 with PP2A catalytic subunits Pph21/22 to form complexes necessary for sustaining cell growth, 
whereas Cdc55 and Tpd3 would inhibit such association43. Although our study does not allow pointing to a 
specific TOR-regulated event to explain the inhibitory effect of AWR5, the observation that deletion of CDC55 
only normalizes the expression of specific subsets of genes altered by awr5 expression (i.e. NCR genes but not 
ribosomal protein encoding genes) or the fact that AWR5-mediated autophagy promotion was not dependent on 
Cdc55 contribute to narrow the possible candidates.
Interestingly, during the course of this work, the cdc55 mutant has been also isolated in a screen for suppres-
sors of the yeast growth inhibition caused by the Erwinia amylovora T3E DspA12. This could suggest that the 
PP2A phosphatase has evolved as a cellular hub, targeted by different pathogens to interfere with plant host cell 
homeostasis. However, DspA caused a specific alteration of the yeast sphingolipid biosynthesis, showing no over-
lap with AWR5-triggered phenotypes other than the Cdc55-dependent growth inhibition. In addition, AWR5 
still caused its toxicity on strains with mutations in the small GTPase rho2 and in the sphingolipid biosynthesis 
gene sur1 (data not shown), which strongly supressed DspA-triggered growth defects12. All these data support a 
different mode of action for these T3Es, only sharing Cdc55 as an intermediate in signal transduction.
TOR functions are conserved across kingdoms; in plants TOR is also a master regulator of the cell, controlling 
the switch between stress and growth44,45. Our data clearly supports the idea that AWR5 alters the TOR pathway 
in plants.
First, awr5 expression in planta results in nitrate reductase activity inhibition. This enzyme has a central role 
in nitrogen metabolism and its inhibition has been previously linked to TOR deficiency and activated nitrogen 
recycling34. Noteworthy, even a minimal escape in awr5 expression visibly impacted plant nitrate reductase activ-
ity, similar to the yeast growth inhibition caused by leaky expression of awr5. This strengthens the notion of a con-
served AWR5 function as an extremely efficient modulator of the TOR pathway in disparate eukaryotic contexts. 
Second, TOR-deficient plants were more susceptible to R. solanacearum infection and plants lacking the CDC55 
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homologues B55α or B55β, showed enhanced resistance to the pathogen. These opposite results are expected if 
the bacterium inhibits TOR signalling, as the B55 activity is repressed by TOR, and demonstrate a novel role for 
the TOR complex in plant defence.
In the context of Ralstonia solanacearum infection it remains a mystery why a bacterial T3E would mimic the 
effect of nitrogen starvation on infected tissues. Interestingly, there are several instances in the literature showing 
modulation of the host metabolism by T3Es. For example, the R. solanacearum effector RipTPS was shown to 
possess trehalose-6-phosphate synthase activity46 and the effector WtsE from Pantoea stewartii was shown to alter 
phenylpropanoid metabolism47.
Furthermore, group A Streptococcus enhances its growth by activation of asparagine metabolism via ER stress 
induction in mammalian cells48. Since ER stress responses are intimately connected with TOR signalling49, it 
is tempting to speculate that AWR5 modulates the TOR pathway to induce ER stress responses and stimulate 
growth by an analogous mechanism to the one proposed in Streptococcus. On an alternative hypothetic scenario, 
AWR5-mediated inhibition of TOR (nitrogen recycling, autophagy, inhibition of protein synthesis… ) would be 
beneficial for the bacterium during the last stages of infection, as it would facilitate plant cell dismissal and con-
sequently nutrient availability.
Methods
Plasmids, strains and gene cloning. All strains and plasmids used in this study are described in 
Supplementary Table S1. For heterologous expression of awrs under the control of the galactose inducible 
promoter (GAL1), expression vectors were constructed by recombining entry clones carrying each of the awr 
ORFs into the Gateway destination vector pAG426GAL-ccdb-HA50 through a Gateway LR reaction (Invitrogen, 
Waltham, Massachusetts, USA). For expression of awr5 fragments in yeast, N-terminal (1368 bp) and C-terminal 
(1821 bp) halves of awr5 as well as a central (1425 bp) fragment overlapping them were amplified from genomic 
DNA.
For integration of the awr genes fused to a C-terminal GFP tag at the locus of URA3 gene in the yeast chro-
mosome, each of them was cloned by Gateway recombination or ligation into the integrative vector pYI-GWY, a 
URA3 plasmid in which the heterologous genes are under the control of a Tet-off promoter created in this study. 
Following linearization with BstBI that cuts inside in URA3 cassette, pYI-GWY derivatives carrying genes awr1 
to awr5 were integrated into the yeast chromosome by double recombination into the URA3 locus in yeast. To 
this end, the wild type strain JA-100 containing a ura3 point mutation was used as recipient, giving rise to uracyl 
autotrophs after awr integration. For expression of awr5 gene in the cdc55Δ mutant yeast strain, cloning was 
performed in two steps. Firstly, a cdc55::KanMX4 cassette from the cdc55Δ strain in the BY4741 background was 
amplified and subsequently introduced into the genome of strain JA-100. Secondly, the awr5 gene fused to the 
C-terminal GFP was integrated into the newly constructed cdc55 strain as described above.
Yeast strains and growth conditions. For expression of awrs or their fragments under the control of the 
galactose promoter, yeast cells were grown for 2 days in SD-Ura + raffinose 2%, then diluted to optical density at 
600 nm of 0.4 in water and plated either in repressing media (glucose) or inducing media (galactose) to monitor 
the effects of AWRs in cell growth/viability. For standard growth inhibition experiments on plates, strains were 
incubated overnight with shaking in selective medium with doxycycline 20 μ g/ml. Cultures were then normalized 
to OD600 = 0.1–0.2 and grown until exponential phase. 1 OD600 of cells were then harvested, washed 2 times with 
sterile water, re-suspended in 1 ml water and 10-fold serially diluted in water four times. Each suspension (5 or 
10 μ l) was dropped either in non-inducing media (+ doxycycline) or inducing media (no doxycycline) onto agar 
plates and then incubated for 2–3 days before photographs were taken.
To test growth viability in liquid media over time and for sample harvesting for RNA isolation, yeast strains 
were grown overnight in rich YPD medium with doxycycline 15 μ g/ml (repressing conditions), then normalized 
to OD600 = 0.05 and grown for 2, 4, 6 or 8 hours in YPD+ dox (non-inducing conditions) and YPD (inducing con-
ditions). Similar growth conditions were carried out for protein extraction and beta-galactosidase assays, using 
selective medium in this case. To test viability of yeast cells expressing awr5 after doxycycline addition, strains 
were grown overnight in either SD-Ura+ dox (non-inducing conditions) or SD-Ura (inducing). Cells were recov-
ered and normalized to OD600 = 0.05 and grown in liquid in SD-Ura+ dox. Samples were harvested at different 
time points, serially 10-fold diluted and plated onto solid SD-Ura+ dox and incubated for 2 days at 28 °C until 
colonies were counted.
For methylene blue staining, yeast cells carrying awr5 were harvested at 6 hours after induction and stained for 
5 minutes with a 0.01% methylene blue solution in glycine buffer. In parallel, the same cells were fixed with for-
maldehyde 37% for 10 mins before methylene blue addition as a positive staining control. Images were obtained 
using a Dapi 395–440/FT 460/LP470 filterset.
To measure yeast cell size, wild-type yeast strains (JA-100) and strains bearing awr5 were grown overnight in 
YPD medium with and without doxycycline (15 μ g/ml). The next day, cultures were normalized to OD600 = 0.05 
and grown in liquid either in YPD+ dox or YPD during 6 and 8 hours. Cells were analyzed with a Scepter 
Handheld Automated Cell Counter (Merck Millipore, Darmstadt, Germany).
To measure induction of autophagy, wild-type and cdc55Δ strains carrying awr5 and ATG8-GFP were grown 
overnight in selective media plus doxycycline. Cultures were then normalized to an OD600 = 0.2, grown until 
exponential phase, normalized again to OD600 = 0.05 and finally grown overnight with or without doxycycline 
until samples were harvested. For autophagy induction after nitrogen starvation JA-100 cells were grown over-
night in SD medium without ammonium sulfate (BD Difco, Franklin Lakes, NJ, USA) and 2% glucose.
DNA microarray analysis. Aliquots of the same samples harvested to test viability of cells express-
ing awr5 in liquid media at 2, 4 and 6 hours after induction were used for microarray analysis. For microarray 
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hybridization, total RNA (8 μg) was employed for cDNA synthesis and labelling using the indirect labelling kit 
(CyScribe Post-Labeling kit; GE Healthcare, Wauwatosa, WI, USA) with Cy3–dUTP and Cy5–dUTP fluorescent 
nucleotides. The cDNA obtained was dried, re-suspended in hybridization buffer and evaluated with a Nanodrop 
spectrophotometer (Nanodrop Technologies, Thermo Scientific, Waltham, MA, USA). The combined fluores-
cently labelled cDNAs were hybridized to yeast genomic microchips constructed in our laboratory by arraying 
6014 different PCR-amplified open reading frames from S. cerevisiae51. Microarrays were processed as described 
previously52, scanned with a ScanArray 4000 apparatus (Packard BioChip Technologies, Perkin Elmer, Waltham, 
MA, USA) and the output was analysed using GenePix Pro 6.0 software. Data collected from 2 biological repli-
cates (two microarrays each, with dye swap) after 2, 4 and 6 h of doxycycline removal (thus triggering expression 
of awr5) were combined. Genes were considered induced or repressed by AWR5 expression when the minus/plus 
doxycycline ratio was ≥ 2.0 or ≤ 0.5, respectively, for both biological replicates. All data has been added to the 
Gene Expression Omnibus (GEO) database under numbers GSE70202, GSE70331 and GSE70835.
qRT-PCR. Two independent biological replicas of the strain carrying awr5 grown in inducing and 
non-inducing conditions were harvested at 4 and 6 hours after induction and subjected to RNA extraction to 
quantify awr5 mRNA levels, whereas of GAP1, MEP2, STM1 and NSR1 levels were only tested from samples 
obtained 6 h after induction. For quantitative real-time PCR, a Light Cycler 480 (Roche, Basel, Switzerland) with 
SYBR Green chemistry was used with three technical replicas. Actin was used as a housekeeping gene to normal-
ize samples.
RNA-seq experiments. Libraries were prepared with the QuantSeq 3′ mRNA kit (Lexogen, Greenland, NH, 
USA) using 0.5 μ g of total RNA purified as above. Sequencing was performed in an Illumina MiSeq machine with 
Reagent Kit v3 (single end, 80–125 nt/read). Two biological replicates were sequenced, obtaining a total number 
of 8.4–12.9 million reads per condition. Mapping of fastq files to generate SAM files was carried out with the 
Bowtie2 software53 in local mode (95.1–97.3% mapped reads). The SAM files were analyzed with the SeqMonk 
software (www.bioinformatics.bbsrc.ac.uk/projects/seqmonk). Mapped reads were counted using CDS probes 
(extended 100 nt downstream the open reading frame because the library is biased towards the 3′ -end of mRNAs) 
and corrected for the largest dataset. Raw data was subjected to diverse filters to remove sequences with a low 
number of reads.
Protein assays. For immunoblots, 30 or 40 OD600 units from overnight yeast cultures grown in non-inducing 
or inducing conditions were were resuspended in 500 μ l of extraction buffer (50 mM Tris-HCl pH7.5, 1 mM 
EDTA, 0.1% Nonidet P-40, 1% glycerol, with complete protease inhibitor (Roche, Basel, Switzerland) and sub-
jected to 10 cycles of 1 minute sonication and 1 minute pauses. Supernatants were recovered after centrifugation 
at 500 g for 10 min at 4 °C. 125 μ g of total protein extracts were separated on polyacrylamide gels and immunoblot 
was performed using anti-GFP mouse monoclonal antibody (clone B-2; Santa Cruz Biotechnology, Dallas, TX, 
USA).
Beta-galactosidase activity was measured from, 2 ml of cultures pelleted 6 hours after induction as described54.
Plant material. Wild type (Wt) Columbia 0, TOR-silenced 35-7 (TOR RNAi)35, b55α and b55β Arabidopsis 
mutant lines36 were used. 3 to 4-week-old N. benthamiana plants were used for transient expression experiments.
Enzymatic activity determinations. To measure nitrate reductase activity, N. benthamiana plants were 
treated two times a week with 2mM-15mM KNO3, then, transient Agrobacterium-mediated transformation 
was performed as previously described20 using the estradiol-inducible vector pMDC7 carrying AWR5 or GUS. 
Protein expression was induced by painting the leaves 14 hours post-agrobacterium infiltration with 20 μ M estra-
diol and Silwet L-77 adjuvant. Whole leaves (1 g) were harvested at 0 and 1 hour after post-estradiol induction 
and homogenized in 3 ml of 0.1 M HEPES-KOH, pH 7.5, 3% polyvinylpolypyrrolidone, 1 mM EDTA and 10 mM 
cysteine. The extracts were filtered through four layers of Miracloth (Merk Millipore, Billerica, USA) and centri-
fuged for 15 minutes at 30,000 × g at 4 °C and nitrate reductase activity measured as described in55.
To measure glucose-6-phosphate dehydrogenase activity N. benthamiana leaves were transiently transformed 
as previously described20 using the estradiol-inducible vector pMDC7 carrying AWR5 or GUS. Protein expression 
was induced by painting the leaves with 20 μ M estradiol and Silwet L-77 adjuvant 14 hours post-agrobacterium 
infiltration. Half-leaves (500 mg) were harvested at 0 and 1 hour after post-estradiol induction and homogenized 
in 500 μ l of 20 mM imidazol, pH 7. The extracts were centrifuged 15 minutes at 1000 × g at 4 °C and the superna-
tant was transferred to a new tube and kept on ice. To determine the activity of glucose-6-phosphate dehydroge-
nase activity 170 μ l of 2x assay buffer (0.1 M imidazol, 0.2 M KCl, 20 mM MgCl2, 2 mM EDTA), 131 μ l H2O, 7 μ l 
of 10 mM NADP and 25 μ l of cell-free extract were sequentially added to a spectrophotometer cuvette and the 
A340 was monitored for a few minutes until stabilization. Then 7 μ l of 50 mM glucose-6-phosphate were added 
and the A340 was recorded, as a measure of Glucose-6-phosphate dehydrogenase activity (expressed as nmoles 
min−1 mg−1 protein).
Pathogenicity assays. R. solanacearum pathogenicity tests were carried out using the soil-drench method 
as described56.
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